Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 41, 197-203, January 1, 1981]
© 1981 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Croy, R. G.
Right arrow Articles by Wogan, G. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Croy, R. G.
Right arrow Articles by Wogan, G. N.

Temporal Patterns of Covalent DNA Adducts in Rat Liver after Single and Multiple Doses of Aflatoxin B11

Robert G. Croy and Gerald N. Wogan2

Department of Nutrition and Food Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139

We examined patterns of covalent modifications of DNA produced in rat liver after exposure to single and multiple doses of aflatoxin B1. The principal product, previously identified as 2,3-dihydro-3-hydroxy(N7-guanyl) aflatoxin B1, was removed rapidly from liver DNA in vivo after a 0.6-mg/kg dose was administered i.p. to male Fischer rats. This lesion had an apparent half-life of 7.5 hr. Similar kinetics of disappearance was seen for two other aflatoxin adducts, one of which was previously identified as an N7-guanine adduct of aflatoxin P1. The kinetics of formation and disappearance differed for two other products believed to be produced by scission of the imidazole ring of the 7-substituted guanine moiety of the principal adduct in the DNA molecule. These adducts were removed slowly, if at all, during the 72-hr period studied. Approximately 20% of the principal N7 adduct initially formed was converted to these products in 24 hr, at which time they were the predominant lesions in DNA. Administration of multiple doses of aflatoxin B1, using a regimen shown to produce a high incidence of hepatocellular carcinoma, caused accumulation of these persistent products in liver DNA over a 14-day period.

1 Financial supported for this work was provided by Grants 5/P01/ES/00597-06 and 5/T32/ES/07020-02 from the N.I.H.

2 To whom requests for reprints should be addressed.

Received 6/26/80. Accepted 10/ 3/80.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
M. T. Simonich, P. A. Egner, B. D. Roebuck, G. A. Orner, C. Jubert, C. Pereira, J. D. Groopman, T. W. Kensler, R. H. Dashwood, D. E. Williams, et al.
Natural chlorophyll inhibits aflatoxin B1-induced multi-organ carcinogenesis in the rat
Carcinogenesis, June 1, 2007; 28(6): 1294 - 1302.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. L. Bedard, M. Alessi, S. Davey, and T. E. Massey
Susceptibility to Aflatoxin B1-Induced Carcinogenesis Correlates with Tissue-Specific Differences in DNA Repair Activity in Mouse and in Rat
Cancer Res., February 15, 2005; 65(4): 1265 - 1270.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y. O. Alekseyev, M. L. Hamm, and J. M. Essigmann
Aflatoxin B1 formamidopyrimidine adducts are preferentially repaired by the nucleotide excision repair pathway in vivo
Carcinogenesis, June 1, 2004; 25(6): 1045 - 1051.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
R. E. Sotomayor, M. Washington, L. Nguyen, R. Nyang'anyi, D. M. Hinton, and M. Chou
Effects of Intermittent Exposure to Aflatoxin B1 on DNA and RNA Adduct Formation in Rat Liver: Dose-Response and Temporal Patterns
Toxicol. Sci., June 1, 2003; 73(2): 329 - 338.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. E. Smela, M. L. Hamm, P. T. Henderson, C. M. Harris, T. M. Harris, and J. M. Essigmann
The aflatoxin B1 formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma
PNAS, May 14, 2002; 99(10): 6655 - 6660.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. E. Smela, S. S. Currier, E. A. Bailey, and J. M. Essigmann
The chemistry and biology of aflatoxin B1: from mutational spectrometry to carcinogenesis
Carcinogenesis, April 1, 2001; 22(4): 535 - 545.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C.-F. Yang, J. Liu, S. Wasser, H.-M. Shen, C. E.-L. Tan, and C.-N. Ong
Inhibition of ebselen on aflatoxin B1-induced hepatocarcinogenesis in Fischer 344 rats
Carcinogenesis, December 1, 2000; 21(12): 2237 - 2243.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
P. Larsson and H. Tjalve
Intranasal Instillation of Aflatoxin B1 in Rats: Bioactivation in the Nasal Mucosa and Neuronal Transport to the Olfactory Bulb
Toxicol. Sci., June 1, 2000; 55(2): 383 - 391.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1981 by the American Association for Cancer Research.